Clearside Biomedical, Inc. Earnings Per Share Diluted

Quick Answer

Clearside Biomedical, Inc. reported Earnings Per Share Diluted of $0.47 (loss) per share for the year ending 2024.

  • Clearside Biomedical, Inc. showed an increase of +11.3% in Earnings Per Share Diluted from 2023 to 2024.
  • This data is from Clearside Biomedical, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
  • XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2020 to 2024), Clearside Biomedical, Inc.'s Earnings Per Share Diluted has declined by 20.5%.
  • Historical annual values: Fiscal year 2024: $0.47 (loss) per share | Fiscal year 2023: $0.53 (loss) per share | Fiscal year 2022: $0.55 (loss) per share | Fiscal year 2021: $0.01 per share | Fiscal year 2020: $0.39 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: